References
- Mody GM, Cardiel MH. Challenges in the management of rheumatoid arthritis in developing countries. Best Pract Res Clin Rheumatol 2008;22:621-41
- Bloomberg School of Public Health, Johns Hopkins University. Noncommunicable chronic diseases in Latin America and the Caribbean. Buenos Aires, Argentina: The Healthy Caribbean Coalition Website; 2009. http://www.healthycaribbean.org/publications/documents/NCD-in-LAC-USAID.pdf. Accessed April 10, 2015
- Burgos-Vargas R, Catoggio LJ, Galarza-Maldonado C, et al. Current therapies in rheumatoid arthritis: a Latin American perspective. Reumatol Clin 2013;9:106-12
- Lichtenstein GR, Hanauer SB, Sandborn WJ; Practice Parameters Committee of American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol 2009;104:465-83
- Gulácsi L, Brodszky V, Baji P, et al. Biosimilars for the management of rheumatoid arthritis: economic considerations. Expert Rev Clin Immunol 2015;11(1 Suppl):43-52
- Birnbaum H, Pike C, Kaufman R, et al. Societal cost of rheumatoid arthritis patient in the US. Curr Med Res Opin 2010;26:77-90
- Sullivan PW, Ghushchyan V, Huang XY, et al. Influence of rheumatoid arthritis on employment, function, and productivity in a nationally representative sample in the United States. J Rheumatol 2010;37:544-9
- Gater A, Kitchen H, Heron L, et al. Development of a conceptual model evaluating the humanistic and economic burden of Crohn's disease: implications for patient-reported outcomes measurement and economic evaluation. Expert Rev Pharmacoecon Outcomes Res 2015;15:643-56
- Ramos-Remus C, Sierra-Jimenez G, Skeith K, et al. Latitude gradient influences the age of onset of rheumatoid arthritis patients. Clin Rheumatol 2007;26:1725-8
- Victoria CR, Sassak LY, Nunes HR. Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. Arq Gastroenterol 2009;46:20-5
- Appleyard CB, Hernández G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis 2004;10:106-11
- Lattimer LD, Chandler MB, Borum ML. Hispanics and inflammatory bowel disease. Inflamm Bowel Dis 2015;21:1214-18
- Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625-39
- Smolen JS, Landewé R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014;73:492-509
- da Mota LM, Cruz BA, Brenol CV, et al. 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis. Rev Bras Reumatol 2012;52:152-74
- Grupo de Estudio de Artritis Reumatoidea. Actualización de las guías de práctica clínica en el tratamiento de la artritis reumatoidea. Buenos Aires, Argentina: Sociedad Argentina de Reumatología; 2013. http://www.reumatologia.org.ar/docs/guias_sar_2013.pdf. Accessed April 10, 2015
- Mora KC, González A, Quintana LG. Guide for treatment of early rheumatoid arthritis in a university hospital in Colombia. Rev Colomb Reumatol 2008;15:79-91
- Gobierno Federal de Estados Unidos Mexicanos. Guia de refrencia rapida diagnostico y tratamient de artritis reumatoide del adulto. Distrito Federal, Mexico: Gobierno Federal de Estados Unidos Mexicanos; 2012. http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/195_ARTRITIS_REUMATOIDE/artritis_reumatoide_RR_CENETEC.pdf. Accessed October 4, 2013
- Citera G, Ficco HM, Alamino RS, et al. Work disability is related to the presence of arthritis and not to a specific diagnosis. Results from a large early arthritis cohort in Argentina. Clin Rheumatol 2015;34:929-33
- Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
- Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010;4:28-62
- Birnbaum HG, Pike C, Banerjee R, et al. Changes in utilization and costs for patients with rheumatoid arthritis, 1996 to 2006. Pharmacoeconomics 2012;30:323-36.
- Singh JA, Christensen R, Wells GA, et al. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev 2009:CD007848
- Sprakes MB, Ford AC, Suares NC, et al. Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experience. Aliment Pharmacol Ther 2010;32:1357-63
- Sussman DA, Kubiliun N, Mulani PM, et al. Comparison of medical costs among patients using adalimumab and infliximab: a retrospective study (COMPAIRS). Inflamm Bowel Dis 2012;18:2043-55
- Binion DG, Louis E, Oldenburg B, et al. Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn’s disease: a meta-analysis. Can J Gastroenterol 2011;25:492-6
- World Bank World Development Indicators. Washington, DC: World Bank; 2013. http://databank.worldbank.org. Accessed August 6, 2013
- International Monetary Fund. World Economic Outlook Database, October 2014. Projected 2013 population. Washington, DC, USA. http://www.imf.org/external/pubs/ft/weo/2012/02/weodata/weoselgr.aspx. Accessed October 3, 2014
- WHO Global Health Expenditures Database. Geneva, Switzerland: WHO; 2013 and 2014. http://apps.who.int/nha/database/PreDataExplorer.aspx?d=1. Accessed February 7, 2013 for Brazil; August 6, 2013, for Argentina; October 3, 2014 for Mexico
- WHO Global Health Expenditures Database. Geneva, Switzerland: WHO; 2014. http://apps.who.int/nha/database/ViewData/Indicators/en. Accessed November 13, 2014 for Colombia
- National Institute of Statistics and Census of Argentina (INDEC). Index of Salaries and Coefficient of Salary Variation. Buenos Aires, Argentina: INDEC; 2013. http://www.indec.gov.ar/nivel4_default.asp?id_tema_1=4&id_tema_2=31&id_tema_3=61. Accessed August 26, 2013
- International Monetary Fund. World Economic Outlook Database, April 2013. Projected 2012 population. Washington, DC, USA. http://www.imf.org/external/pubs/ft/weo/2013/01/weodata/weoselgr.aspx. Accessed August 5, 2013
- Banco Central do Brasil. Foreign exchange and wage indicators. Brasilia, Brazil: Banco Central do Brasil; 2014. http://www.bcb.gov.br/pec/Indeco/Ingl/ie5-35i.xls. Accessed October 3, 2014
- ILO Global Wage Database - Mexico National Institute of Statistics and Geography. ILO Global Wage Database - Mexico National Institute of Statistics and Geography. Geneva, Switzerland: International Labor Organization; 2013.http://www.ilo.org/travail/areasofwork/wages-and-income/WCMS_142568/lang–en/index.htm. Accessed September 30, 2013
- Culpepper Salary Budget Survey Data Tables 2012–2013. Culpepper and Associates Inc. (publisher and author).Alpharetta, GA: Culpepper and Associates Inc.; 2013. http://www.culpepper.com/dl.asp?f=/surveys/practices/SalaryBudget/20122013/Culpepper20122013SalaryBudgetSurveyDataTables.xlsx. Accessed May 20, 2014
- Culpepper Salary Budget Survey Data Tables 2013–2014. Culpepper and Associates Inc. (publisher and author). Alpharetta, GA: Culpepper and Associates Inc.; 2014. http://www.culpepper.com/dl.asp?f=/surveys/practices/SalaryBudget/20122013/Culpepper20122013SalaryBudgetSurveyDataTables.xlsx. Accessed May 20, 2014 and November 13, 2014
- National Institute of Statistics and Census of Argentina (INDEC). Serie histórica del Indice de Precios al Consumidor (IPC) en el Gran Buenos Aires. Buenos Aires, Argentina: INDEC; 2013. http://www.indec.mecon.ar/informacion-de-archivo.asp Accessed August 26, 2013.
- World Bank Population Data. Washington, DC: World Bank; 2015. http://data.worldbank.org/region/LAC; http://data.worldbank.org/country/argentina. Accessed September 15, 2015
- International Monetary Fund. World Economic Outlook Database, April 2013. Projected 2012 GDP current prices, national currency. Washington, DC. http://www.imf.org/external/pubs/ft/weo/2013/02/weodata/weoselgr.aspx. Accessed August 5, 2013
- Catay E, Del Cid CC, Narváez L, et al. Cost of rheumatoid arthritis in a selected population from Argentina in the prebiologic therapy era. Clinicoeconomics and Outcomes Res 2012;4:219-25
- Chermont GC, Kowalski SC, Ciconelli RM, et al. Resource utilization and the cost of rheumatoid arthritis in Brazil. Clin Exp Rheumatol 2008;26:24-31
- Instituto Brasiliero de Geografia e Estatistica. IPCA Index. Rio de Janeiro, Brazil: Instituto Brasiliero de Geografia e Estatistica; 2013. http://www.ibge.gov.br/english/estatistica/indicadores/precos/inpc_ipca/defaultseriesHist.shtm. Accessed February 20, 2013
- Montoya N, Gomez L, Velez M, et al. Costos directos del tratamiento de pacientes con artritis reumatoide en Medellín, Colombia. Rev Colomb Reumatol 2011;18:26-33
- Banco de la Republic Colombia. Indice de precios al consumidor Bogota, Colombia, 2013. http://banrep.gov.co/series-estadisticas/see_precios_ipc.htm. Accessed August 6, 2013
- Álvarez-Hernández E, Peláez-Ballestas I, Boonen A, et al. Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis. Reumatol Clin 2012;8:168-73
- Instituto Nacional de Estadística y Geografía. Índices de Precios al Consumidor. INPC Nacional. Aguascalientes, Mexico, 2013. http://www.inegi.org.mx/est/contenidos/proyectos/inp/inpc.aspx. Accessed February 5, 2013
- de Azevedo AB, Ferraz MB, Ciconelli RM. Indirect costs of rheumatoid arthritis in Brazil. Value Health 2008;11:869-77
- Sokka T, Kautiainen H, Pincus T, et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study. Arthritis Res Ther 2010;12:R42
- Piedrahita H. Costs of work-related musculoskeletal disorders (MSDs) in developing countries: Colombia case. Int J Occup Saf Ergon 2006;12:379-86
- Araujo G, Fonseca M. Cost of patient care in patients with Crohn’s disease in Brazil: public health perspective. Value Health 2007;10:A149
- Morais AD, Pereira ML, Paloni EDMP, et al. Real life treatment cost of rheumatoid arthritis, psoriasis, Crohn’s disease and ulcerative colitis in the Brazilian private health care system. Poster presented at: ISPOR 17th Annual International Meeting; June 2–6, 2012; Washington, DC, USA
- Loomes DE, Teshima C, Jacobs P, et al. Health care resource use and costs for Crohn's disease before and after infliximab therapy. Can J Gastroenterol 2011;25:497-502
- Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol 2003;98:1064-72
- Birnbaum H, Pike C, Kaufman R, et al. Employer model of workplace impacts of anti-TNF therapy for rheumatoid arthritis. J Occup Environ Med 2009;51:1167-76
- Augustsson J, Neovius M, Cullinane-Carli C, et al. Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry). Ann Rheum Dis 2010;69:126-31
- Feagan BG, Reilly MC, Gerlier L, et al. Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn's disease in the PRECiSE 2 study. Aliment Pharmacol Ther 2010;31:1276-85
- Senna, ER, De Barros ALP, Silva EO, et al. Prevalence of rheumatic diseases in Brazil: A study using the COPCORD approach. J Rheumatol 2004;31:594-7
- Titton DC, Silveira IG, Louzada-Junior P, et al. Brazilian biologic registry: BiobadaBrasil implementation process and preliminary results. Rev Bras Reumatol 2011;51:152-60
- International Monetary Fund. World Economic Outlook Database, October 2012. Projected 2012 population. Washington, DC, 2012. http://www.imf.org/external/pubs/ft/weo/2012/02/weodata/weoselgr.aspx. Accessed February 20, 2013
- International Monetary Fund. World Economic Outlook Database, October 2012. Projected 2012 GDP current prices, national currency. Washington, DC, 2012. http://www.imf.org/external/pubs/ft/weo/2012/02/weodata/weoselgr.aspx. Accessed February 20, 2013
- Santos-Moreno P, Gonzalez-Malaver F, Fandiño C, et al. Improvement in activity levels short term in a large cohort of patients with rheumatoid arthritis implementing the recommendations: target to treat. Rev Colomb Reumatol 2011;18:2(Suppl):61
- International Monetary Fund. World Economic Outlook Database, October 2014. Projected 2013 GDP, national currency. Washington, DC, 2014. http://www.imf.org/external/pubs/ft/weo/2012/02/weodata/weoselgr.aspx. Accessed October 3, 2014
- Feagan BG, Bala M, Yan S, et al. Unemployment and disability in patients with moderately to severely active Crohn's disease. J Clin Gastroenterol 2005;39:390-5
- Hay JW, Hay AR. Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol 1992;14:309-17
- Gibson TB, Ng E, Ozminkowski RJ, et al. The direct and indirect cost burden of Crohn's disease and ulcerative colitis. J Occup Environ Med 2008;50:1261-72
- Yu AP, Cabanilla LA, Wu EQ, et al. The costs of Crohn's disease in the United States and other Western countries: a systematic review. Curr Med Res Opin 2008;24:319-28
- Ministerio da Saude do Brasil. Estudos de avaliacao economica de technologias em saude [Economic evaluation studies of technologies in health]. Brasilia, Brazil, 2009. http://www.ispor.org/PEguidelines/source/Economic-Evaluation-Guidelines-in-Brazil-Final-Version-2009.pdf. Accessed May 7, 2013 and October 3, 2014. Portuguese
- Ministerio de la Proteccion Social Republica de Colombia. Guía Metodológica para la elaboración de Guías de Atención Integral en el Sistema General de Seguridad Social en Salud colombiano, May Bogota, Colombia, 2010. http://www.minsalud.gov.co/salud/Documents/Gu%C3%ADa%20Metodol%C3%B3gica%20para%20la%20elaboraci%C3%B3n%20de%20gu%C3%ADas.pdf. Accessed August 6, 2013
- Augustovski F, Garay OU, Pichon-Riviere A, et al. Economic evaluation guidelines in Latin America: a current snapshot. Expert Rev Pharmacoecon Outcomes Res 2010;10:525-37
- Spindler A, Bellomio V, Berman A, et al. Prevalence of rheumatoid arthritis in Tucumán, Argentina. J Rheumatol 2002;29:1166-70
- Scublinsky D, Venarotti H, Citera G, et al. The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city of Buenos Aires province. J Clin Rheumatol 2010;16:317-21
- Cardiel MH, Latin American Rheumatology Associations of the Pan-American League of Associations for Rheumatology (PANLAR); Grupo Latinoamericano de Estudio de Artritis Reumatoide (GLADAR). First Latin American position paper on the pharmacological treatment of rheumatoid arthritis. Rheumatology (Oxford) 2006;45(Suppl 2):ii7-ii22
- Peláez-Ballestas I, Sanin LH, Moreno-Montoya J, et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl 2011;86:3-8
- Correa M, Lencina V, del Moral R, et al. Impacto de las Guías de Práctica Clínica para el Tratamiento de la Artritis Reumatoidea. Rev Arg Reumatol 2012;23:18-23
- Caballero-Uribe V, Londoño JD, Chalem P. Tratamiento de la artritis reumatoide en Colombia. Revista Colombiana de Reumatología 2002;9:242-50
- Economic Commission for Latin America and the Caribbean (ECLAC). Total population 2013. Santiago, Chile, 2013. http://interwp.cepal.org/anuario_estadistico/anuario_2013/en/index.asp. Accessed April 1, 2014
- Goycochea-Robles MV, Arce-Salinas CA, Guzmán-Vázquez S, Cardiel-Ríos MH. Prescription rheumatology practices among Mexican specialists. Arch Med Res 2007;38:354-9
- de Jesús Yepes Barreto I, Carmona R, Díaz F, et al. Prevalence and demographic characteristics of inflammatory bowel disease in Cartagena, Colombia. Rev Col Gastroenterol 2010:25:107-11
- Miltenburger C, Munkombwe M, Lekander I. A survey of barriers to treatment access in rheumatoid arthritis in major Latin American Countries – Argentina, Brazil and Mexico. i3 innuvo, Medford, MA, 2010. http://www.comparatorreports.se/LA%20RA%20barrier%20report_FINAL.pdf. Accessed May 9, 2016